To further investigate whether inhibiting MDM recruitment could ameliorate psoriasis pathology, we employed a CCR2 antagonist in an IMQ-induced murine psoriasiform dermatitis model. This evidence concerns the gene CCR2 and Psoriasiform dermatitis.